Latest Ratings for MRK
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Feb 2022 | SVB Leerink | Maintains | Outperform | |
| Jan 2022 | JP Morgan | Maintains | Overweight | |
| Dec 2021 | Daiwa Capital | Initiates Coverage On | Neutral |
Assessing Merck & Co: Insights From 4 Financial Analysts
Where Today's News Shapes Tomorrow
